AIDS Kaposi Sarcoma new research best therapy cost effective in Africa

New research indicates the best available chemotherapy for Kaposi Sarcoma, which is infrequently used in Africa, is cost effective and would improve clinical outcomes.

Although antiretroviral therapy has markedly improved survival in people with AIDS-associated Kaposi sarcoma (a type of cancer caused by a virus), the condition is still a life-threatening problem in low- and middle-income countries.
#aids #Kaposisarcoma #sme